Truvada, a popular drug used in the treatment of HIV, causes serious and life threatening side effects including kidney failure, bone fractures, and osteoporosis. While the drug does offer benefits to patients who are HIV positive, many have suffered significantly as a result of taking this toxic and dangerous drug. Critics now say a safer alternative to Truvada could have prevented many Truvada injuries, yet drug company officials chose to delay its release to maximize profit./p>
Despite its serious side effects, Truvada was a hugely profitable drug for Gilead; at its height, Truvada sales yielded $11 billion annually. Critics say Gilead purposefully halted the development of TAF, the safer version of Truvada, to maximize profits while Truvada was still under patent protection. Then in 2014, when Truvada’s patent expiration was looming, the company released the safer version of the drug and obtained a new patent which extends until 2032. In the years when Gilead executives had paused TAF's production, millions of HIV positive patients suffered unnecessarily from kidney failure, bone density loss, and fractures. In 2016, Gilead faced a Truvada lawsuit for 'blocking affordable access to a lifesaving HIV drug' known as TAF. The pharmaceutical company was also warned on multiple occasions by the FDA for misrepresenting and downplaying Truvada kidney and bone side effects.
Persons and the family members of persons who developed kidney problems or experienced broken bones from Truvada may be entitled to real compensation for suffering, pain, and loss through filing a Truvada lawsuit against Gilead. All too often, we learn after the fact that a pharmaceutical giant prioritized company profits over consumer safety. Filing a Truvada lawsuit will serve to exert pressure on the company to become a better corporate citizen, in addition to seeking compensation American families deserve.
Diminished bone mineral density and kidney problems are anticipated side effects of HIV, but patients who take Truvada are particularly prone to osteoporosis and kidney failure.
Humans rely on a complex system of more than 200 bones to provide structure and stability to protect vital organs and help us move. Throughout life, our bone cells die off and are regenerated. Osteoporosis occurs when degradation of the bone cells occurs more rapidly than regeneration, resulting in a net loss in bone mineral density. Patients suffering from osteoporosis are prone to fractures, particularly in the wrists, spine, and hips.
Osteoporosis is a normal side effect of aging, and is also more common among patients who are HIV positive. However, research shows that bone degeneration is markedly accelerated in patients taking Truvada. Truvada bone damage occurs rapidly;Â on average, a person's overall bone mineral density drops by 2-6% in the first two years on Truvada. Developing Truvada osteoporosis is an ongoing risk for who is taking or has ever taken Truvada.
The kidneys serve as a filtration system for the body, processing substances such as pharmaceutical drugs in order to remove harmful waste from the body.
The kidneys are made of millions of nephrons, comprised of blood vessels and fluid-collecting tubes. Each day, the kidney's fluid-collecting tubes and blood vessels (nephrons) filter the body's entire blood supply 30 to 40 times, cycling through approximately 200 quarts of blood every day.
A particularly strong substance such as Truvada, which is effective at keeping the development of HIV at bay, taxes the kidneys significantly. The risk of kidney failure from Truvada increased by 33% each year a patient takes the drug. Studies indicate Truvada accumulates in the kidney tubules, causing harm to the nephrons and resulting in progressive Truvada kidney problems, ultimately resulting in full-blown kidney failure if not halted in time:
When American families suffer as a result of corporate negligence and greed, our attorneys see it as their duty to pursue justice, no matter how complex the case. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today. In this case, the drug maker knowingly delayed the production of a safer drug that could have prevented nearly a decade's worth of patients being exposed to Truvada kidney and bone side effects in order to maximize profits. At the same time, the company was repeatedly scolded by the FDA for engaging in false and unethical advertising practices. Our Truvada lawyers believe persons who were harmed by Truvada kidney failure or osteoporosis may be eligible for real compensation by filing a claim against Gilead.
Our experienced Tasigna lawyers have seen the aftereffects of numerous drug recalls. Aware of the gravity of Tasigna atherosclerosis lawsuits, this national* drug litigation law firm is offering its significant resources to provide clients with the best Tasigna attorney representation possible. These Tasigna lawyers will provide a free case review to persons and family members of persons who have been harmed by Tasigna. Never warned of the risk for Tasigna atherosclerosis, these individuals have suffered through no fault of their own. The Tasigna lawyers aim to achieve compensation for loss and suffering, while holding Novartis accountable for its actions.
We will represent all persons involved in a Truvada lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Persons who developed osteoporosis, suffered from broken bones, or experienced kidney failure while taking Truvada, and then family members of such persons, qualify for a free, no-obligation case review from our Truvada attorneys. This site's chat feature or complete the online contact form and one of our Truvada kidney lawyers will contact you promptly to discuss your case.
The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, Truvada, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including Truvada hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.
A leader in cancer research at Harvard University asserts that perhaps 10,000 cases of ovarian cancer can be blamed each year on perineal talc use in the US. Despite the existence of evidence that talc-based products are dangerous and can cause cancer, talc is not regulated in the US. The American Cancer Society estimates that in 2013, about 22,240 new cases of ovarian cancer will be diagnosed, while 14,030 women will die as a result of ovarian cancer in the US.
Roundup weed killer, manufactured by Monsanto, uses a chemical called glyphosate, which the World Health Organization labeled as a probable carcinogen in 2015. Roundup is the most popular of all glyphosate-based herbicides. As little as 8 hours of Roundup exposure has been linked to an increased risk of non-Hodgkin lymphoma, multiple myeloma, and leukemia. Millions of gardeners, landscapers, farmers and others have been exposed to Roundup cancer risks.
Physiomesh is a form of surgical mesh that has been used in hernia repair surgeries. Ethicon Physiomesh was used in ventral hernia repair and has been pulled from the market due to a high failure rate. Persons with Ethicon Physiomesh have experienced an array of complications that include pain, infection, hernia recurrence, adhesion or scar-tissue buildup, intestinal blockage, bleeding, perforation, organ damage, and the need for revision surgery.